FDA Inspection 1205427 — CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services

CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services — FEI 1672092

The FDA completed an inspection of CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services on May 3, 2023 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 3, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Houston, TX (United States)